Top 10 Pharma Companies In India In 2022

Healthcare facilities and medicines have become critical as a result of the COVID-19 epidemic. India, the world's second-most populous country, has witnessed multiple cases of Covid-19, with the number of cases continuing to rise. India's pharmaceutical industry is also expanding and altering lives by providing essential facilities. The turnover of pharmaceutical firms in India was 18.12 billion USD in 2018 and 19.14 billion USD in fiscal year 2019, according to the Ministry of Chemicals and Fertilizers. In April 2021, the domestic medicine market saw sales of 2.15 billion dollars. It has climbed by 51.5 percent since April 2020, when it was $1.42 billion. As of April 2021, the moving yearly turnover is $20.88 billion, up from $19.64 billion in April 2020.

We've compiled a list of some of the greatest pharmaceutical businesses in India that produce world-class pharmaceuticals and dominate the Indian pharmaceutical industry.

Sun Pharmaceutical Industries

Founded: 1983
Owner: Dilip Shanghvi
Headquarters: Goregaon, Mumbai
Revenue: $4.7 billion (FY20)

In 2020, Sun Pharmaceutical Industries had a sales of $4.7 billion. It is India's largest multinational pharmaceutical corporation. Sun Pharmaceuticals was founded in 1983. Mr. Dilip Shanghvi, who is also the MD of Sun Pharmaceuticals, founded it. The business began selling products to treat psychiatric disorders. In addition to medicinal formulations, the company now offers gastroenterology and diabetology formulations. In terms of overall income, Sun Pharmaceutical Industries is India's largest pharmaceutical firm.

Founded: 1990
Owner: Murali Divi
Headquarters: Hyderabad
Revenue: $780 million (FY20)

Divi's Laboratories Limited, situated in Hyderabad, India, is an Indian multinational pharmaceutical firm. Divi's Laboratories first opened its doors in 1990. Active pharmaceutical ingredients (APIs) and intermediates are manufactured by Divi's Laboratories Ltd. This Indian pharmaceutical firm specialises in the development of leading generic chemicals, nutraceutical components, custom API synthesis, and intermediates for worldwide innovators. Divi's Laboratories is one of the world's major API firms, with $780 million in revenue expected in 2020 and exports to over 95 countries.

Dr. Reddy's Laboratories

Founded: 1984
Owner: Dr. Kallam Anji Reddy
Headquarters: Hyderabad
Revenue: $2.4 billion (FY20)

Anji Reddy created Dr. Reddy's Laboratories in 1984. It is a multinational pharmaceutical firm based in India. It is well-known in India and abroad for producing a wide range of medications. Over 190 pharmaceuticals, 60 active pharmaceutical ingredients for drug producers, diagnostics kits, critical care, and biotechnology items are among their offerings. It is India's fifth-largest pharmaceutical firm, with a revenue of US$2.4 billion expected in 2020. Canagliflozin, Ramipril, Ibuprofen, Naproxen, Atorvastatin, Nizatidine, Naproxen Sodium, and other Dr. Reddy's medications are significant.

Cipla Limited

Founded: 1935
Owner: Yusuf Hamied
Headquarters: Mumbai
Revenue: $2.5 billion (FY20)

Cipla is an Indian multinational pharmaceutical and biotechnology corporation founded in 1935 by Khwaja Abdul Hamied and headquartered in Mumbai. Cipla's Non-Executive Chairman is Yusuf Hamied. In terms of overall sales, it is India's fourth-largest pharmaceutical firm. This Indian pharmaceutical business focuses on developing drugs for respiratory, cardiovascular, arthritis, diabetes, weight loss, depression, and other conditions.

Cipla expects to generate $2.5 billion in revenue in 2020 and employs more than 22,036 people. Invagen Pharmaceuticals is one of Cipla's subsidiaries. They are the world's largest producer of antiretroviral medications.

Emcure Pharmaceuticals

Founded: 1983
Owner: Satish Ramanlal Mehta

Headquarters: Pune
Revenue:  $870.25 million (FY21)

Emcure Pharmaceuticals is a Pune-based firm started by Satish Ramanlal Mehta in 1983. Emcure Pharmaceuticals was founded with the goal of meeting the world's massive healthcare requirements. Emcure Pharmaceuticals began as a single manufacturing site in Pune and has grown steadily over the years to include a diverse variety of world-class manufacturing facilities in API, formulations, and biotechnology. Emcure has established itself as a vertically integrated pharmaceutical firm with infrastructure, talents, and resources that are not only equivalent to the top pharma companies in Mumbai, India, but also to the best in the world. Emcure's strengths can be summarised as API manufacturing, formulations, and biotechnology.

Biocon Limited

Founded: 1978
Owner: Kiran Mazumdar-Shaw
Headquarters: Bengaluru
Revenue:  $296.46 million (INR 2,223 crore in Q3 FY22)

Biocon is India's most well-known pharmaceutical firm, having been founded in 1978. Biocon Limited is a generic active medicines manufacturer. Bengaluru is the headquarters of the company. Biocon Limited's products are sold on a massive scale all over the world. Biocon employs around 9000 employees and, as of FY20, the company has total assets of $824 million and revenue of $659.31 million (INR 4,885 crores).

Torrent Pharma

Founded: 1959
Owner: Sudhir Mehta
Headquarters: Ahmedabad
Revenue:  $168.12 million (Rs 1,261 crore in FY21)

Torrent is one of India's leading pharmaceutical businesses. As of 2020, it has a revenue of US$1.1 billion and is situated in Ahmedabad. Dahej, Pithampur, Gujarat, and Madhya Pradesh are among Torrent's manufacturing locations. Torrent Pharma develops pharmaceuticals for the Central Nervous System, gastrointestinal pain management, gastrointestinal diabetes, and anti-infective segments.

Lupin Limited

Founded: 1968
Owner: Mrs. Manju D Gupta (W/o Desh Bandhu Gupta)
Headquarters: Mumbai
Revenue:  $2.2 billion (FY20)

Lupin is a Mumbai-based multinational pharmaceutical corporation. Desh Bandhu Gupta established Lupin in 1968. It is India's 12th-largest firm by market capitalization and consequently one of the country's most well-known pharmaceutical companies. In 2020, Lupin will generate $2.2 billion in revenue. The company manufactures and sells pharmaceuticals in a variety of areas, including paediatrics, cardiology, anti-infectives, diabetology, asthma, and anti-tuberculosis.

Cadila Healthcare Limited

Founded: 1952
Owner: Pankaj Patel
Headquarters: Ahmedabad
Revenue:  $2.1 billion (FY21)

Cadila Healthcare Limited (Cadila) was established in 1952. Zydus Cadila is another name for it. It is a pharmaceutical firm based in Ahmedabad, India. It is one of India's major pharmaceutical businesses, with revenue of US$2.1 billion in 2021. Ramabhai Patel created the company.

Cadila Healthcare Limited is also a maker of herbal, cosmetics, and other OTC goods, as well as providing superior diagnostics. Based on a voluntary licence arrangement with Gilead, the company also develops generics for hepatitis C treatment. Cadila manufactures API at three locations in India: Ankleshwar, Vadodara, and Patalganga.

Aurobindo Pharma Limited

Founded: 1986
Owner:  P. V. Ramaprasad Reddy and Mr. K. Nityananda Reddy
Headquarters: Hyderabad
Revenue:  $3.3 billion (FY20)

In 1986, Aurobindo Pharma Limited was founded. It sells over 300 items in over 125 countries, and APIS is its most profitable division, accounting for 35 percent of total revenue. It is India's second-largest pharmaceutical company, with revenue of US$3.3 billion expected in 2020. Aurobindo Pharma Limited manufactures and sells medications in the fields of neurology, cardiovascular medicine, antiretrovirals, anti-diabetics, gastroenterology, cephalosporins, and other areas.